ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, supplying promising breakthroughs across several professional medical and industrial applications. With its structural similarity to Normally derived human serum albumin, OsrHSA offers a safer, much more trusted alternative for ther